Who Paid My Doc
Howard Baum
Endocrinology, Diabetes & Metabolism Nashville, TN Medical Doctor
NPI 1104862234 CMS profile 964199
Vanderbilt Univ Med Ctr 7465 Mrb IV, 2213 Garland Avenue, Nashville, TN 37232
General payments
$0
Research payments
$50
Ownership & investment interest
$0
Research they led as principal investigator
$81,111
Through program year 2023, Howard Baum of Nashville, TN is reported in the CMS Open Payments database as having received $0 across 0 general payments and $50 in research payments paid to them. Separately, studies naming them as principal investigator received $81,111 in research payments, paid to institutions rather than to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 7th percentile of Endocrinology, Diabetes & Metabolism profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
1 row| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2023 | Research | $50 | 1 |
Prescribing to Medicare patients
Part D · data year 2024 · 38 drugsPart D claims
1,690
Drug cost
$962,707
Branded share of claims
69.2%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Ozempic Semaglutide | Brand | 188 | $236,041 | |
| Jardiance Empagliflozin | Brand | 65 | $96,860 | |
| Somatuline Depot Lanreotide Acetate | Brand | 12 | $95,579 | |
| Humulin R U-500 Kwikpen Insulin Regular, Human | Brand | 25 | $75,561 | |
| Tymlos Abaloparatide | Brand | 28 | $70,862 | |
| Mounjaro Tirzepatide | Brand | 43 | $60,708 | |
| Sandostatin Lar Depot Octreotide Acetate,mi-Spheres | Brand | 13 | $55,816 | |
| Trulicity Dulaglutide | Brand | 41 | $49,977 | |
| Tresiba Flextouch U-200 Insulin Degludec | Brand | 26 | $36,741 | |
| Farxiga Dapagliflozin Propanediol | Brand | 19 | $25,498 |
The 10 drugs with the highest cost, of 38 counted.
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 6,527 Part D prescribers listed as Endocrinology; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 7 billing codesPaid by Medicare
$12,827
Medicare patients
174
Services billed
222
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Diabetes | 68% | |
| Arthritis | 44% | |
| Chronic kidney disease | 40% | |
| Ischemic heart disease | 35% | |
| Depression | 22% | |
| Osteoporosis | 21% | |
| Heart failure | 18% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
1 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Endocrinology, Diabetes & Metabolism in Tennessee
Alan Cohen
Endocrinology, Diabetes & Metabolism · Memphis, TN
Craig Wierum
Endocrinology, Diabetes & Metabolism · Nashville, TN
Pascal Dauphin
Endocrinology, Diabetes & Metabolism · Hendersonville, TN
Shimon Harary
Endocrinology, Diabetes & Metabolism · Memphis, TN
Lisa Myers
Endocrinology, Diabetes & Metabolism · Germantown, TN
Amit Vora
Endocrinology, Diabetes & Metabolism · Knoxville, TN
Related records
Endocrinology, Diabetes & Metabolism in Tennessee
Practitioners in the same specialty and state, ranked by reported value.
All Endocrinology, Diabetes & Metabolism
Everyone recorded under this specialty, nationwide.
Doctors in Tennessee
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.